Ravindra Kumar, SVP & Chief Scientific Officer at ACCELERON PHARMA INC (XLRN), sold 1,203 shares at $38.34 ($46K) on 2018-04-03, disclosed to the SEC on 2018-04-04.
Scheduled sale ($46k) by SVP & Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.34 | 1,103 | $42K | 91.5% |
| 2 | $39.16 | 100 | $4K | 8.5% |
| Total | $38.41 avg | 1,203 | $46K | 100% |
| Filing → |
| XLRN | SELL | 2019-01-04 | $249K | — | Filing → |
| XLRN | SELL | 2018-01-04 | $182K | — | Filing → |
| XLRN | SELL | 2017-09-14 | $196K | — | Filing → |